LOS ANGELES, Nov. 6, 2012 (GLOBE NEWSWIRE) -- Hospitalized heart failure patients given an investigational drug had improved symptoms and other clinical benefits including fewer deaths, than those given standard of care plus a placebo, according to late-breaking clinical trial research presented at the American Heart Association’s Scientific Sessions 2012.
